[Carminomycin in drug combination in breast cancer and soft tissue sarcomas].

Author: AssekritovaI V, GorbunovaV A, LichinitserM R

Paper Details 
Original Abstract of the Article :
Thirteen patients with neglected mammary cancer were treated with karminomycin in combination with hexamethylmelamine. Twelve out of the 13 patients were previously subjected many times to cytostatic and hormonal therapy. A significant therapeutic effect was registered in 5 out the 13 patients (38 p...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/411416

データ提供:米国国立医学図書館(NLM)

Carminomycin: A Potential Oasis in the Desert of Cancer

The field of oncology is often a quest to find effective treatments for a wide range of cancers. This research explores the potential of carminomycin, a chemotherapy drug, in combination with other medications, to treat breast cancer and soft tissue sarcomas. It's like discovering a new and potentially powerful tool in the fight against cancer.

A Novel Approach: Combining Therapies

The study evaluated carminomycin in combination with hexamethylmelamine for breast cancer and with methotrexate and cyclophosphane for soft tissue sarcomas. The findings revealed promising therapeutic effects in a significant proportion of patients. It's like combining the strengths of different weapons in a battle, creating a more effective attack on the cancer cells.

Navigating the Side Effects: A Careful Approach

The study also acknowledges the potential side effects of these drug combinations, emphasizing the importance of careful monitoring and management. It's like navigating a terrain with potential hazards, ensuring the safety and well-being of those undergoing treatment.

Dr. Camel's Conclusion

This research provides valuable insights into the potential of carminomycin as a component of combination therapies for breast cancer and soft tissue sarcomas. It's a journey of discovery, like a camel venturing into a vast and unknown desert, where every new finding holds the promise of improved outcomes for patients.

Date :
  1. Date Completed 1977-12-29
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

411416

DOI: Digital Object Identifier

411416

Related Literature

SNS
PICO Info
in preparation
Languages

Russian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.